Supplied in a kit containing a pre-filled syringe and two needles, Prenoxad (naloxone) is licensed for emergency use to reverse life-threatening respiratory depression caused by natural or synthetic opioids. It should be administered by intramuscular injection as part of a resuscitation intervention.
Prenoxad is intended to be carried by individuals at risk of opioid overdose. Prescribers must assess the competence of the patient or representative to administer the product in the appropriate circumstances.
Further information: Martindale